Ausgabe 8/2022
Inhalt (9 Artikel)
Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?
Hasitha Manohar, Adam S. Potter, Efstratios Koutroumpakis, Anita Deswal, Nicolas L. Palaskas
COVID-19 and Cardiometabolic Health: Lessons Gleaned from the Pandemic and Insights for the Next Wave
Ahmed A. Kolkailah, Kayla Riggs, Ann Marie Navar, Amit Khera
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know
Johnathon Seth Parham, Anne Carol Goldberg
SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently?
Mahmoud Al Rifai, L. Kristin Newby, Ajith P. Nair, Arunima Misra, Joseph G. Rogers, Savitri Fedson, Salim S. Virani
LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated?
Lamija Ferhatbegović, Denis Mršić, Sabina Kušljugić, Belma Pojskić
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management
Mohamad B. Taha, Tamer Yahya, Priyanka Satish, Rachel Laird, Arthur S. Agatston, Miguel Cainzos-Achirica, Kershaw V. Patel, Khurram Nasir
Bioactives in the Food Supply: Effects on CVD Health
Sisi Cao, Connie M. Weaver
Statins in Pregnancy: Can We Justify Early Treatment of Reproductive Aged Women?
Amelie Pham, Aleksandra Polic, Lynsa Nguyen, Jennifer L. Thompson
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions
Melody Hermel, Stacy Tsai, Luis Dlouhy, Anupama B K, Jamal S. Rana, Sourbha S. Dani, Salim S. Virani